We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Results Shows PKR Superior to TKR

By HospiMedica International staff writers
Posted on 23 Oct 2017
One-year study outcomes suggest that partial knee replacement (PKR) provides better results for medial osteoarthritis (OA) than total knee replacement (TKR).

Researchers at the University of Oxford (United Kingdom), the Hospital for Special Surgery (HSS, New York, NY, USA), and other institutions participating in the total or partial knee arthroplasty trial (TOPKAT), have recently reported one-year results. More...
The study included 528 patients with medial compartment knee OA treated at 27 sites by 63 surgeons. The Oxford Knee Score (OKS) at one year was the primary endpoint, with secondary outcomes including activity scores, patient satisfaction, and complications.

The results revealed that at one year, OKS was 1.9 points in favor of PKR, and the secondary variables mostly reflected this pattern. 89% of PKR patients reported they would undergo the operation again, compared with 77% of TKR patients. Overall, there were 8 (3.1%) complications requiring readmission in the PKR group and 12 (4.8%) in the TKR group. A composite outcome for failure showed that 11% of PKRs failed, compared with 15% in the TKR group. Expertise based analysis emphasized the differences between groups. The study was published in the October 2017 issue of Arthroscopy.

“Late stage knee osteoarthritis of the medial compartment can be treated using total knee replacement or partial unicompartmental replacement. The cost efficacy implications for the healthcare provider are substantial,” concluded lead author Professor David Beard, MD, PhD, of Oxford University, and colleagues. “These early results suggest superiority of PKR over TKR for medial compartment knee OA at one year; however, in view of the importance of longer term outcome and failure of knee replacement, five year results from TOPKAT are essential.”

During TKR, arthritic bone and cartilage are removed from the knee and replaced with anatomically shaped metal and plastic components impacted onto the bone or fixed using polymethylmethacrylate (PMMA) cement. The surgery involves detachment of part of the quadriceps muscle from the patella, which is displaced to one side to allow exposure of the distal end of the femur and the proximal end of the tibia. PKR is an alternative approach that it is only performed on one of the knee compartments – the medial, lateral, or patellofemoral compartment.

Related Links:
University of Oxford
Hospital for Special Surgery

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.